创伤性脑损伤后的心脏损伤:临床后果与管理
本文综述创伤性脑损伤(TBI)后心脏损伤的临床后果与管理。TBI患者中约25-35%发生心脏损伤,机制涉及脑-心交互、全身炎症反应和儿茶酚胺释放。最常见表现为校正QT(QTc)延长和室上性心律失常,患病率高达一般成人人群的5至10倍。β受体阻滞剂可能通过干预这一适应不良过程带来益处,可限制对心律、循环和脑代谢的病理影响,并可能减轻代谢性酸中毒、改善脑灌注,但其作用仍需进一步临床研究阐明。
要点
- TBI患者中约25-35%发生心脏损伤,是ICU期间常见的颅外并发症,可影响死亡率和神经结局。
- TBI后心脏损伤最常见表现为QTc延长和室上性心律失常,患病率高达一般成人人群的5至10倍。
- 其他心脏损伤形式包括区域性室壁运动改变、肌钙蛋白升高、心肌顿抑或Takotsubo心肌病。
- β受体阻滞剂可能通过干预脑-心交互的适应不良过程带来益处,可限制对心律、循环和脑代谢的病理影响,并可能减轻代谢性酸中毒、改善脑灌注。
- 作者认为,需要进一步临床研究来阐明新的治疗策略在限制重型TBI患者心脏功能障碍中的作用。
适用人群与场景
- 创伤性脑损伤(TBI)患者,尤其是入住重症监护室期间出现颅外并发症者。
处置流程与药物剂量
- β受体阻滞剂可能通过干预TBI后脑-心交互的适应不良过程带来益处,可限制对心律、循环和脑代谢的病理影响,并可能减轻代谢性酸中毒、改善脑灌注。
研究设计与关键结果
- TBI后心脏损伤影响约25-35%的TBI患者。
- TBI后心脏损伤最常见表现为校正QT(QTc)延长和室上性心律失常,患病率高达一般成人人群的5至10倍。
- 其他形式的心脏损伤包括区域性室壁运动改变、肌钙蛋白升高、心肌顿抑或Takotsubo心肌病。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,β受体阻滞剂可能通过干预脑-心交互的适应不良过程带来益处,可限制对心律、循环和脑代谢的病理影响,并可能减轻代谢性酸中毒、改善脑灌注。
- 作者认为,需要进一步临床研究来阐明新的治疗策略在限制重型TBI患者心脏功能障碍中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Traumatic brain injury (TBI) is a significant public health issue because of its increasing incidence and the substantial short-term and long-term burden it imposes. This burden includes high mortality rates, morbidity, and a significant impact on productivity and quality of life for survivors. During the management of TBI, extracranial complications commonly arise during the patient's stay in the intensive care unit. These complications can have an impact on both mortality and the neurological outcome of patients with TBI. Among these extracranial complications, cardiac injury is a relatively frequent occurrence, affecting approximately 25-35% of patients with TBI. The pathophysiology underlying cardiac injury in TBI involves the intricate interplay between the brain and the heart. Acute brain injury triggers a systemic inflammatory response and a surge of catecholamines, leading to the release of neurotransmitters and cytokines. These substances have detrimental effects on the brain and peripheral organs, creating a vicious cycle that exacerbates brain damage and cellular dysfunction. The most common manifestation of cardiac injury in TBI is corrected QT (QTc) prolongation and supraventricular arrhythmias, with a prevalence up to 5 to 10 times higher than in the general adult population. Other forms of cardiac injury, such as regional wall motion alteration, troponin elevation, myocardial stunning, or Takotsubo cardiomyopathy, have also been described. In this context, the use of β-blockers has shown potential benefits by intervening in this maladaptive process. β-blockers can limit the pathological effects on cardiac rhythm, blood circulation, and cerebral metabolism. They may also mitigate metabolic acidosis and potentially contribute to improved cerebral perfusion. However, further clinical studies are needed to elucidate the role of new therapeutic strategies in limiting cardiac dysfunction in patients with severe TBI.
参考来源
- Coppalini G, Salvagno M, Peluso L, et al. Cardiac Injury After Traumatic Brain Injury: Clinical Consequences and Management. Neurocrit Care. 2023. PMID: 37378852. doi:10.1007/s12028-023-01777-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。